135 related articles for article (PubMed ID: 27910191)
1. Tintelnotia, a new genus in Phaeosphaeriaceae harbouring agents of cornea and nail infections in humans.
Ahmed SA; Hofmüller W; Seibold M; de Hoog GS; Harak H; Tammer I; van Diepeningen AD; Behrens-Baumann W
Mycoses; 2017 Apr; 60(4):244-253. PubMed ID: 27910191
[TBL] [Abstract][Full Text] [Related]
2. In Vitro Susceptibility Profiles of Eight Antifungal Drugs against Clinical and Environmental Strains of Phaeoacremonium.
Badali H; Khodavaisy S; Fakhim H; de Hoog GS; Meis JF; Chowdhary A
Antimicrob Agents Chemother; 2015 Dec; 59(12):7818-22. PubMed ID: 26369976
[TBL] [Abstract][Full Text] [Related]
3. In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species.
Skóra M; Bulanda M; Jagielski T
Antimicrob Agents Chemother; 2015 Sep; 59(9):5827-9. PubMed ID: 26100698
[TBL] [Abstract][Full Text] [Related]
4. Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses.
Öz Y; Özdemir HG; Gökbolat E; Kiraz N; Ilkit M; Seyedmousavi S
Mycopathologia; 2016 Apr; 181(3-4):225-33. PubMed ID: 26612621
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis.
Lalitha P; Shapiro BL; Srinivasan M; Prajna NV; Acharya NR; Fothergill AW; Ruiz J; Chidambaram JD; Maxey KJ; Hong KC; McLeod SD; Lietman TM
Arch Ophthalmol; 2007 Jun; 125(6):789-93. PubMed ID: 17562990
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility testing of Aspergillus spp. against voriconazole, itraconazole, posaconazole, amphotericin B and caspofungin.
Shi JY; Xu YC; Shi Y; Lü HX; Liu Y; Zhao WS; Chen DM; Xi LY; Zhou X; Wang H; Guo LN
Chin Med J (Engl); 2010 Oct; 123(19):2706-9. PubMed ID: 21034656
[TBL] [Abstract][Full Text] [Related]
7. Antifungal susceptibility of ocular fungal pathogens recovered from around the world against itraconazole, voriconazole, amphotericin B, and caspofungin.
Ozdemir HG; Oz Y; Ilkit M; Kiraz N
Med Mycol; 2012 Feb; 50(2):130-5. PubMed ID: 21599550
[TBL] [Abstract][Full Text] [Related]
8. In vitro activities of nine antifungal drugs against 81 Phialophora and Cyphellophora isolates.
Feng P; Najafzadeh MJ; Sun J; Ahmed S; Xi L; de Hoog GS; Lai W; Lu C; Klaassen CH; Meis JF
Antimicrob Agents Chemother; 2012 Nov; 56(11):6044-7. PubMed ID: 22948876
[TBL] [Abstract][Full Text] [Related]
9. [Tintelnotia destructans: new enemy at the gates].
Habbe KJ; Frings A; Schrader S; Roth M; MacKenzie C; Walther G; Kurzai O; Geerling G
Ophthalmologe; 2018 Nov; 115(11):948-950. PubMed ID: 29273865
[TBL] [Abstract][Full Text] [Related]
10. In vitro antifungal susceptibility and molecular identity of 99 clinical isolates of the opportunistic fungal genus Curvularia.
da Cunha KC; Sutton DA; Fothergill AW; Gené J; Cano J; Madrid H; Hoog Sd; Crous PW; Guarro J
Diagn Microbiol Infect Dis; 2013 Jun; 76(2):168-74. PubMed ID: 23558007
[TBL] [Abstract][Full Text] [Related]
11. Keratomycosis due to Tintelnotia destructans refractory to common therapy treated successfully with systemic and local terbinafine in combination with polyhexamethylene biguanide.
Behrens-Baumann WJ; Hofmüller W; Tammer I; Tintelnot K
Int Ophthalmol; 2019 Jun; 39(6):1379-1385. PubMed ID: 29705891
[TBL] [Abstract][Full Text] [Related]
12. In vitro antifungal susceptibility of Cladophialophora carrionii, an agent of human chromoblastomycosis.
Deng S; de Hoog GS; Badali H; Yang L; Najafzadeh MJ; Pan B; Curfs-Breuker I; Meis JF; Liao W
Antimicrob Agents Chemother; 2013 Apr; 57(4):1974-7. PubMed ID: 23380718
[TBL] [Abstract][Full Text] [Related]
13. In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens.
Marangon FB; Miller D; Giaconi JA; Alfonso EC
Am J Ophthalmol; 2004 May; 137(5):820-5. PubMed ID: 15126145
[TBL] [Abstract][Full Text] [Related]
14. Molecular identification and antifungal susceptibility profiles of clinical strains of Fonsecaea spp. isolated from patients with chromoblastomycosis in Rio de Janeiro, Brazil.
Coelho RA; Brito-Santos F; Figueiredo-Carvalho MHG; Silva JVDS; Gutierrez-Galhardo MC; do Valle ACF; Zancopé-Oliveira RM; Trilles L; Meyer W; Freitas DFS; Almeida-Paes R
PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006675. PubMed ID: 30048450
[TBL] [Abstract][Full Text] [Related]
15. In Vitro Activities of Eight Antifungal Drugs against a Global Collection of Genotyped Exserohilum Isolates.
Chowdhary A; Hagen F; Curfs-Breuker I; Madrid H; de Hoog GS; Meis JF
Antimicrob Agents Chemother; 2015 Oct; 59(10):6642-5. PubMed ID: 26239995
[TBL] [Abstract][Full Text] [Related]
16. In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis.
Cuenca-Estrella M; Gomez-Lopez A; Buitrago MJ; Mellado E; Garcia-Effron G; Rodriguez-Tudela JL
Antimicrob Agents Chemother; 2006 Jun; 50(6):2248-50. PubMed ID: 16723597
[TBL] [Abstract][Full Text] [Related]
17. Tintelnotia destructans Keratitis: A Clinicopathological Report and Review of the Literature.
Kaufmann C; Arnold M; Schipf A; Bruderer VL; Iselin KC
Cornea; 2021 Mar; 40(3):380-382. PubMed ID: 33252388
[TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibility patterns of clinically important Trichophyton and Epidermophyton species against nine antifungal drugs.
Badali H; Mohammadi R; Mashedi O; de Hoog GS; Meis JF
Mycoses; 2015 May; 58(5):303-7. PubMed ID: 25757042
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
Bueno JG; Martinez C; Zapata B; Sanclemente G; Gallego M; Mesa AC
Clin Exp Dermatol; 2010 Aug; 35(6):658-63. PubMed ID: 19874354
[TBL] [Abstract][Full Text] [Related]
20. In Vitro Triple Combination of Antifungal Drugs against Clinical Scopulariopsis and Microascus Species.
Yao L; Wan Z; Li R; Yu J
Antimicrob Agents Chemother; 2015 Aug; 59(8):5040-3. PubMed ID: 26014943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
